среда, 15 февраля 2017 г.

Merck Alzheimer's drug fails in 1 study; another continues

Merck Alzheimer's drug fails in 1 study; another continues


Merck & Co. will stop its study of an experimental Alzheimer's drug in people with mild or moderate symptoms because interim results showed "virtually no chance" of any benefit.



from Biotech News